Private Advisor Group LLC bought a new position in shares of Tempus AI, Inc. (NASDAQ:TEM – Free Report) during the fourth ...
Artificial intelligence tools continue to be a focal point among publicly traded digital health companies looking to improve ...
A remarkable start to the year, marked by a 160% surge, has had investors paying close attention to healthcare tech company ...
In a regulatory filing, Tempus AI (TEM) disclosed that its CEO Eric Lefkofsky disposed of 3.24M shares of company stock in a series of ...
We recently compiled a list of the 18 AI News and Ratings Making Waves on Wall Street. In this article, we are going to take ...
Tempus AI (NASDAQ:TEM – Get Free Report) was downgraded by stock analysts at JPMorgan Chase & Co. from an “overweight” rating ...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...
1d
Zacks.com on MSNTempus AI Falls 15% on Weak Q4 but EBITDA View Strong: Buy the Dip?Tempus AI TEM, an innovator in artificial intelligence-based healthcare solutions, has been attracting investors' interest ...
Completing its initial public offering on June 14, Tempus AI stock closed at $40.25, and while it rose above this mark from time to time in the second half of 2024, the stock ended the year on a sour ...
Cathie Wood and Ark Invest seized the opportunity on Tuesday to buy the dip on Tempus AI ( NASDAQ: TEM) as the stock took a ...
1d
Hosted on MSNTempus AI Is a Buy, If You Can Handle the VolatilityCompanyOverview|NASDAQ:TEM] Tempus AI (NASDAQ: TEM) is an emerging AI player in the healthcare field with a robust outlook ...
Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results. See why I remain bullish on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results